Severity of peripheral neuropathy, in different domains, in type II diabetic patients
Barra lateral de artigos
Conteúdo do artigo principal
Resumo
Introduction: Diabetes mellitus is a chronic degenerative disease that can significantly impact both life expectancy and quality of life among affected populations, primarily by disrupting metabolic control and exacerbating disease complications. Objective: To assess the severity of neuropathy across four domains (pain, loss of sensation, postural instability, and depression) in individuals with diabetes mellitus. Materials and Methods: This was a cross-sectional, descriptive-correlational, and qualitative study The study population comprised diabetic individuals attending outpatient clinics for diabetic foot care at Hospital de S. João - Unidade de Valongo and Centro Hospitalar do Alto Ave in Guimarães. Variables included gender, age, type and duration of diabetes, neuropathic characteristics, balance, dependency/independence, and depression. Results: Regarding neuropathy severity, most diabetic patients exhibited loss of sensation and moderate pain, with no apparent postural instability or depression. However, both instability and depression were observed when neuropathic signs were present. Conclusions: The presence of neuropathic signs was associated with increased postural instability, reduced functionality, and a higher prevalence of depressive symptoms. Furthermore, a positive relationship was observed between pain severity and depressive symptomatology.
Detalhes do artigo
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Direitos Autorais | Atribuição CC - BY
Esta licença permite que outros distribuam, remixem, adaptem e criem a partir do seu trabalho, mesmo para fins comerciais, desde que lhe atribuam o devido crédito pela criação original. É a licença mais flexível de todas as licenças disponíveis. É recomendada para maximizar a disseminação e uso dos materiais licenciados. Particularmente com relação à licença CC-BY, é preciso destacar que, por ser o tipo de licença mais aberta tanto com relação às permissões e acessos, também é a licença que permite o uso dos conteúdos para fins comerciais. Isso significa que terceiros podem obter lucros com o trabalho alheio a qualquer momento, sem que o criador tenha qualquer controle. Ver o Resumo da Licença | Ver o Texto Legal
Referências
Anandhanarayanan, A., Teh, K., Goonoo, M., Tesfaye, S., & Selvarajah, D. (2022). Diabetic Neuropathies. Endotext. https://www.ncbi.nlm.nih.gov/books/NBK279175/
Andrade, L. P., Stella, F., Barbieri, F. A., Rinaldi, N. M., Hamanaka, A. Y., & Gobbi, L. T. Efeitos de tarefas cognitivas no controle postural de idosos: Uma revisão sistemática. Motricidade, 2011; 7, 1-10.
Armstrong, D. G. Loss of protective sensation: a practical evidence based definition. J Foot Ankle Surg., 1999; 79-80.
Associação Protectora dos Diabéticos de Portugal. (2010). Pé Diabético: Caminhando para um futuro melhor. Lisboa: Lidel.
Barreto M, Kislaya I, Gaio V et al (2018) Prevalence, awareness, treatment and control of diabetes in Portugal: results from the first national health examination survey (INSEF 2015). Diabetes Res Clin Pract 140:271–278. https:// doi. org/ 10. 1016/j. diabr es. 2018. 03. 05)
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W., Comparison of beck depression inventories.Journal of personality assessment, 1996; 588-97.
Berg, K., Wood-Dauphinee, S., Williams, J., & Gayton, D., Measuring balance in the elderly: Validation on a instrument.Can J Public Health, 1992; 7-11.
Bibbo, C., Patel, D. V., Orth, M. C., O`Brien, I. D., & Corrall, R. M. Diabetic neurophaty. Foot Ankle Clin, 2006; 753-74.
Boulton A. J. (2004). The diabetic foot: from art to science. Diabetologia , 1343-53
Boulton, A. J. M., Vinik, A. I. & Arezzo, J. C. (2005);, Diabetic neuropathies: A statement by the american diabetic association. Diabetes Care9, 56-62.
Boulton, A. J., Armstrong, D. G., Albert, S. T., Frykberg, R. G., Kirkman, M. S., Hellman, R., et al. (2008). Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the american diabetes association, with endorsement by the american association of clinical endocrinologists. Diabetes Care , 1679-85.
Boulton. (2014). Neuropatias diabéticas. Em H. C. Pedrosa, L. Vilar, & A. M. Boulton, Neuropatias e Pé Diabético (pp. 1-16). São Paulo: AC Farmacêutica.
Cimbiz, A., & Cakir, O. (2005). Evaluation of balance and physical fitness in diabetic neuropathic patients. Journal od diabetes and it complications, 160-64.
Correia, L.G., Boavida, J. M., Almeida, J. P. F., Cardoso, S. M., Dores, J., Duarte, J. S., et al. Diabetes: Factos e números 2013 – Relatório Anual do Observatório Nacional da Diabetes. Sociedade Portuguesa de Diabetologia, 2013; 9.
Costanzo, L. Fisiologia (5.ª ed.). Rio de Janeiro: Elsevier, 2014.
Davoudi, M., Rezaei, P., Rajaeiramsheh, F., Ahmadi, S. M., & Taheri, A. A. (2021). Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients. Health and Quality of Life Outcomes, 19(1), 49. https://doi.org/10.1186/s12955-021-01697-w
Dyck, P. J., Kratz, K. M., Kames, J. L., Litchy, W. J., Klein, R., Pach, J. M., & Wilson, D. M. The prevalence by staged severity of various types of diabetic neurophaty, retinophaty, and nephropathy in a population based cohort: the rochester diabetic neurophaty study. Neurology, 1993; 817-24.
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., & Gottdiener, J. Frailty in older adults. J Geronto A Biol Sci Med Sci, 2000.
Galer, B. S., Gianas, A., & Jensen, M. P. (2000). Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract, 123-8.
Jensen, T. Anticonvulsants in neurophatic pain: rationale and clinical evidence. Eur J Pain, 2002; 61-68.
Lawton, M. P., & Brody, M. H. Assessment of older people: Self-maintaining and instrumental activities of daily living. The Gerontologist, 1969; 179-86.
Moreira, R. O., Castro, A. P., Papelbaum, M., Appolinário, J. C., Ellinger, V. C., & Coutinho, W. F. Tradução para o português e avaliação da confiabilidade de numa escala para o diagnóstico da polieuropatia distal diabética. Arq Bras Endocrinol Metab, 2005; 944-50.
Oliveira, A. S., & Gabbai, A. A. Abordagem terapêutica da dor neuropática na clínica neurológica. Rev. Neurociências, 1998; 87-95.
Paschoal, S. M. Autonomia e independência. In M. Papaléo Neto, Gerontologia São Paulo: Atheneu.1996; (pp. 313-23).
Pedrosa. (2004). Aspetos clínicos, avaliação e fundamentos do tratamento da neuropatia diabética. Endocrinologist, 1-36.
Pedrosa, Tavares, F. T., Saigg, M. A., Batista, M. C., & Carvalho, P. S. (2014). Anexo. In H. C. Pedrosa, L. Vilar, & A. J. Boulton, Neuropatia e pé diabético (pp. 295-302). São Paulo: AC Farmacêutica.
Pérez, J. A., Vitarella, G., Guzmán, J. R., Pedrosa, H. C., Rojas, N., & Braver, J. D. (2010). Guías alad de pie diabético. Rev. ALAD , 73-84.
Peyrot, M., & Rubin, R. R. Levels and risks of depression and anxiety simptomatology among diabetic adults. Diabetes Care, 1997; 585-90.
Pomeroy, V. M., Warren, C. M., & Honeycombr, C. Mobility and dementia: Is physiotherapy treatment during respite care effective? Int J Geriat Psychiatry, 1999; 389-97.
Prevadiab. (2010). First diabetes prevalence study in portugal. Diabetes Med, 879-81.
Quattrini & Tesfay. (2003). Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev.
Raposo, J. F. (2020). Diabetes: Factos e Números 2016, 2017 e 2018*. Revista Portuguesa de Diabetes, 19–26. http://www.revportdiabetes.com/wp-content/uploads/2020/05/RPD-Mar%C3%A7o-2020-Revista-Nacional-p%C3%A1gs-19-27.pdf
Roy, C. The roy adaptation. Connecticut: Appleton & Lange, 1999.
Schestatsky, P. Definition, diagnosis and treatment of neurophatic pain. Serviço de Neurologia do Hospital de Clínicas de Porto Alegre, 2008; 1-187.
Schmid, H., Neumann, C., & Brugnara, L. Diabetes and polyneuropathy of the lower limbs in the perspective of diabetologists. J Vasc Br, 2003; 37-48.
Serra, L. M. Pé diabético: Manual para a prevenção da catástrofe. Porto: Lidel, 2008; 32,114.
Tesfaye & Selvarajah. (2012). Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev, 8-14.
Tesfaye, S., Chaturvedi, N., Eaton, S. E., Witte, D., Ward, J. D., & Fuller, J. (2005). Vascular risk factors and diabetic neurophaty. New England J Med, 341-50.
Vileikyte, L. & Gonzalez, J. S. Reconhecimento e manuseio das questões psicossociais na neuropatia diabética. In H. C. Pedrosa, L. Vilar, & A. J. Boulton, Neuropatias e pé diabético. São Paulo: AC Farmacêutica, 2014; (pp. 118-41).
Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Simma, A. A., & Feldman, E. L. (2009). Elevated triglycerides correlate with progression of diabetic neurophaty. Diabetes, 1634-40.
Wodd, S. (2004). Factors influencing the selection of appropriate pain assessment tools. Nurs Times, 42-7.
Yardley, L. Fear of fallings: links between imbalance and anxiety. Rev Clin Gerontol, 2003; 195-201.
Ziegler, D. Treatment of diabetic neurophaty and neurophatic pain: how far have we come. Diabetes Care, 2008; 255-61.
Zimerman, G. I. Velhice: Aspetos biopsicossociais. São Paulo: Artemed Editora, 2000.